Your AI-Trained Oncology Knowledge Connection!

News

Video

Predictive Biomarkers for Treatment With Amivantamab Plus Lazertinib Among EGFR-Mutated NSCLC in the Post-Osimertinib Setting: Analysis of Tissue IHC and ctDNA NGS

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Subscribe Now!
Related Videos
Timothy S. Fenske, MD, MS
2 experts in this video
2 experts in this video
Sheela Rao, MBBS, MD, FRCP
2 experts in this video
2 experts in this video
Related Content
Image credit: Nittaya – stock.adobe.co
March 21st 2025

NMPA Grants Conditional Approval to Tazemetostat for EZH2-Mutant R/R Follicular Lymphoma

Ibrahim T. Aldoss, MD, associate professor, Division of Leukemia, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope; Elias Jabbour, MD, professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
March 20th 2025

Ponatinib Monotherapy Maintains MRD Negativity Following TKI/Chemotherapy Treatment in Ph+ ALL: With Ibrahim T. Aldoss, MD; and Elias Jabbour, MD

Sheela Rao, MBBS, MD, FRCP
March 21st 2025

Improving Outcomes for Patients With Anal Cancer By Raising Awareness

D. Ross Camidge, MD, PhD; Alexandra Rink, PhD, medical physicist, Princess Margaret Cancer Centre, clinician scientist, Princess Margaret Research Institute, associate professor, Departments of Radiation Oncology and Medical Biophysics, University of Toronto
March 19th 2025

How Medical Physicists Contribute to Optimized Oncologic Outcomes: With D. Ross Camidge, MD, PhD; Alexandra Rink, PhD

Joshua Feinberg, MD
March 21st 2025

AI-Powered Scout Platform Could Enhance Oncology Decision-Making With Data- and Expert-Based Insights

Image Credit: Sebastian Kaulitzki – stock.adobe.com
March 21st 2025

First-Line Atezolizumab Is Suitable in Platinum-Based Chemotherapy Ineligible mUC